Procurement of an App for Cognitive and Language Training in Neurological Disorders
DAK-Gesundheit, HamburgTED 671227-2026
value not stated1 lot, 1 year
Thu 29 Oct12:00 in Berlin
1day
DAK-Gesundheit
Hamburg, Germany
Listed tenders
CountryTenderValueClosesDays left
BGM-Addiction Prevention
DAK-Gesundheit, HamburgTED 677607-2026
value not stated2 lots, 6 years
Fri 30 Oct12:00 in Berlin
2days
Headquarters + Academy: RV Locksmith
DAK-Gesundheit, Hamburgoeffentlichevergabe.de
value not stated1 lot
Wed 4 Nov12:00 in Berlin
7days
Provision and web-based use of a comparison tool for statutory health insurance funds
DAK-Gesundheit, HamburgTED 709402-2026
value not stated1 lot, 2 years
Fri 13 Nov12:00 in Berlin
16days
Application to support a healthy lifestyle among adult insured persons with obesity
DAK-Gesundheit, HamburgTED 719946-2026
value not stated1 lot, 4 years
Tue 17 Nov12:00 in Berlin
20days
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Guselkumab (strength exclusively 100 mg), ATC L04AC16, for the period 01.12.2026 – 31.03.2027
DAK-Gesundheit, HamburgTED 713237-2026
€11 lot, 4 months
Fri 5 Feb12:00 in Berlin
100days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Bimekizumab, ATC L04AC21, for the period 01.10.2026 - 31.03.2027
DAK-Gesundheit, HamburgTED 569497-2026
€11 lot, 6 months
Fri 5 Feb12:00 in Berlin
100days
Conclusion of a non-exclusive rebate agreement under § 130a paragraph 8 SGB V for the Active Substance Vedolizumab, ATC L04AG05 for the period 01.07.2025 - 30.06.2027
DAK-Gesundheit, HamburgTED 752767-2025
€11 lot, 2 years
Sat 1 May12:00 in Berlin
185days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Filgotinib, ATC L04AF04, for the period 01.11.2025 - 31.10.2027
DAK-Gesundheit, HamburgTED 602894-2025
€11 lot, 2 years
Sun 5 Sep12:00 in Berlin
312days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Glycopyrronium bromide, ATC R03BB06, for the period 01.11.2025 - 31.10.2026 (plus extension option 1x12 months)
DAK-Gesundheit, HamburgTED 603091-2025
€11 lot, 1 year
Sun 5 Sep12:00 in Berlin
312days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Follitropin beta, ATC G03GA06, for the period 01.11.2025 - 31.10.2027
DAK-Gesundheit, HamburgTED 603888-2025
€11 lot, 2 years
Sun 5 Sep12:00 in Berlin
312days
Conclusion of a non-exclusive discount agreement pursuant to Section 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Allergen extract from exclusively meadow foxtail pollen, ATC V01AA02, for the period 01.10.2026 – 31.10.2027
DAK-Gesundheit, HamburgTED 571536-2026
€11 lot, 13 months
Sun 5 Sep12:00 in Berlin
312days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substances Formoterol, Beclometasone, Glycopyrronium, for the period 01.11.25 - 31.10.26 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 606785-2025
€11 lot, 1 year
Sun 5 Sep12:00 in Berlin
312days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Sodium phenylbutyrate, ATC A16AX03, for the period 01.11.2025 - 31.10.2027
DAK-Gesundheit, HamburgTED 603012-2025
€11 lot, 2 years
Sun 5 Sep12:00 in Berlin
312days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Tiotropium bromide exclusively in the form of solution for inhalation, ATC R03BB04 for the period 01.11.25 - 31.10.27
DAK-Gesundheit, HamburgTED 604908-2025
€11 lot, 2 years
Sun 5 Sep12:00 in Berlin
312days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Lenograstim, ATC L03AA10 for the period 01.11.2025 - 31.10.2027
DAK-Gesundheit, HamburgTED 604678-2025
€11 lot, 2 years
Sun 5 Sep12:00 in Berlin
312days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Raltegravir, ATC J05AJ01 for the period 01.11.2025 - 31.10.2027
DAK-Gesundheit, HamburgTED 604976-2025
€11 lot, 2 years
Sun 5 Sep12:00 in Berlin
312days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Birch Pollen Allergen Extract exclusively Dafo SUT, ATC V01AA05 for the period 01.11.2025 - 31.10.2027
DAK-Gesundheit, HamburgTED 605005-2025
€11 lot, 2 years
Sun 5 Sep12:00 in Berlin
312days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Clobetasol exclusively in the form of foam, ATC D07AD01 for the period 01.11.2025 - 31.10.2027
DAK-Gesundheit, HamburgTED 604590-2025
€11 lot, 2 years
Sun 5 Sep12:00 in Berlin
312days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Aflibercept (excluding 114, 3 mg/ml), ATC S01LA05 for the period 01.12.2025 - 30.11.2027
DAK-Gesundheit, HamburgTED 685877-2025
€11 lot, 2 years
Tue 5 Oct12:00 in Berlin
342days
Contracts and who won them
Source: award notices on TED.
SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.